US5913842A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Retrograde delivery catheter and method for inducing cardioplegic arrest
Assignee: Edwards Lifesciences LLC
•
Filing: 1998-02-11
•
Granted: 1999-06-22
•
Expires: 2018-02-11
Abstract
Abstract retrograde delivery catheter includes at its distal end a balloon configured to occlude the coronary sinus of a patient's heart, and has a length and flexibility which allow the distal end to be positioned in the coronary sinus with the proximal end extending transluminally to a peripheral vein such as an internal jugular vein and out of the body through a puncture therein. The delivery catheter has a delivery lumen extending between its proximal and distal ends which is configured to allow a cardioplegic fluid to be delivered at a flow rate of at least 200 ml/min with a pump pressure less than 300 mm Hg, thereby allowing cardioplegic arrest to be maintained using a blood cardioplegic fluid without causing excessive hemolysis. In a method of inducing cardioplegic arrest according to the invention, the patient is placed on cardiopulmonary bypass, the coronary arteries are isolated from remainder of the arterial system, and the delivery catheter is positioned transluminally in the coronary sinus from a peripheral vein. A cardioplegic fluid is then delivered to the coronary sinus through the delivery catheter at a flow rate of at least 200 ml/min and a pump pressure less than 300 mm Hg. The heart may be vented by withdrawing blood from the pulmonary artery through a catheter introduced through a peripheral vein, or withdrawing blood from the aortic root through an aortic catheter introduced through a peripheral artery.
Inventors
- 👤 Stephen W. Boyd
- 👤 John H. Stevens
- 👤 Philip C. Evard
- 👤 Craig L. Adams
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 08:04
CPC Classifications
A; A61; A61B; A61B17/00; A61B17/28; A61B17/29; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2427; A61F2/243; A61F2/2433; A61M; A61M1/00; A61M1/36; A61M1/3621; A61M1/3653; A61M1/3659; A61M25/00; A61M25/0021; A61M25/0041; A61M25/01; A61M25/0105; A61M25/0133; A61M25/0147; A61M25/0152; A61M25/06; A61M25/0662; A61M25/10; A61B17/32; A61B17/320016; A61B17/00234; A61B2017/00238; A61B2017/00243; A61B18/00; A61B2018/00053; A61B2018/00214; A61B2018/0022; A61B2018/00232; A61B2018/0025; A61B2018/00261; A61F2/2412; A61F2/2436; A61M1/3613; A61M25/0023; A61M25/0026; A61M25/003; A61M2025/0031; A61M2025/004; A61M25/0067; A61M25/0074; A61M25/0075; A61M2025/0076; A61M2025/0078; A61M2025/0161; A61M25/02; A61M2025/028; A61M2025/1043; A61M2025/1047; A61M2025/1052; A61M2025/1077; A61M2025/1095; A61M2202/00; A61M2202/04; A61M2202/0468; A61M2202/047; A61M2205/00; A61M2205/11; A61M2205/36; A61M2205/366; A61M2210/00; A61M2210/12; A61M2210/125; A61M2210/127; A61M25/0032; A61M25/0125; A61M25/1002
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
145 words
A method of inducing cardioplegic arrest of a patient's heart, the heart having an aorta leading away therefrom to a peripheral artery, coronary arteries in communication with the aorta, and a brachiocephalic artery in communication with the aorta downstream from the coronary arteries, the method comprising: withdrawing blood from a peripheral vein; oxygenating the withdrawn blood; returning the oxygenated blood to a peripheral artery; isolating the coronary arteries from the oxygenated blood returned to the peripheral artery; venting fluid from the heart; positioning a retrograde delivery catheter in a peripheral vein and advancing the retrograde delivery catheter transluminally into a coronary sinus in the heart; and delivering a cardioplegic fluid comprising blood and a cardioplegic agent through the retrograde delivery catheter to the coronary sinus at a flow rate of at least 200 m/min. and at a pump pressure of less than 300 mm Hg.
Claim 2
Independent Claim
145 words
A method of inducing cardioplegic arrest of a patient's heart, the heart having an aorta leading away therefrom to a peripheral artery, coronary arteries in communication with the aorta, and a brachiocephalic artery in communication with the aorta downstream from the coronary arteries, the method comprising: withdrawing blood from a peripheral vein; oxygenating the withdrawn blood; returning the oxygenated blood to a peripheral artery; isolating the coronary arteries from the oxygenated blood returned to the peripheral artery; venting fluid from the heart; positioning a retrograde delivery catheter in a peripheral vein and advancing the retrograde delivery catheter transluminally into a coronary sinus in the heart; and delivering a cardioplegic fluid comprising blood and a cardioplegic agent through the retrograde delivery catheter to the coronary sinus at a flow rate of at least 200 m/min. and at a pump pressure of less than 300 mm Hg.
Claim 3
Dependent Claim
18 words
The method of claim 1 wherein the cardioplegic fluid has a viscosity of at least about 3.0 centipoise.
Claim 4
Dependent Claim
35 words
The method of claim 1 wherein the cardioplegic fluid comprises a mixture of blood and a cardioplegic agent in a ratio of at least about two parts blood to one part cardioplegic agent by volume.
Claim 5
Dependent Claim
14 words
The method of claim 3 wherein the cardioplegic agent comprises an aqueous KCl solution.
Claim 6
Dependent Claim
24 words
The method of claim 1 wherein the cardioplegic fluid is cooled to a temperature of 3° C.-10° C. before delivery to the coronary sinus.
Claim 7
Dependent Claim
32 words
The method of claim 1 further comprising expanding an expandable member on a distal end of the retrograde delivery catheter to occlude the coronary sinus during the step of delivering cardioplegic fluid.
Claim 8
Dependent Claim
29 words
The method of claim 1 wherein the step of positioning comprises advancing the retrograde delivery catheter over a guidewire slidably positioned in a lumen in the retrograde delivery catheter.
Claim 9
Dependent Claim
33 words
The method of claim 1 wherein the retrograde delivery catheter has at least two bends in a distal portion thereof, the method further comprising straightening the two bends during the step of positioning.
Claim 10
Dependent Claim
25 words
The method of claim 1 wherein the step of positioning comprises using fluoroscopy to observe the position of the retrograde delivery catheter in the heart.
Claim 11
Dependent Claim
28 words
The method of claim 9 wherein the positioning step further comprises injecting a radiopaque contrast fluid through the retrograde delivery catheter to determine the position thereof using fluoroscopy.
Claim 12
Dependent Claim
52 words
The method of claim 1 wherein the step of isolating comprises positioning an endoaortic catheter in a peripheral artery, advancing the endoaortic catheter into the aorta, and expanding an expandable member on the distal end of the endoaortic catheter to occlude an aortic lumen between the coronary arteries and the brachiocephalic artery.
Claim 13
Dependent Claim
29 words
The method of claim 11 wherein the step of venting comprises withdrawing fluid from the aortic lumen upstream of the expandable member through a lumen in the endoaortic catheter.
Claim 14
Dependent Claim
36 words
The method of claim 1 wherein the step of venting comprises withdrawing fluid from a pulmonary artery through a venting catheter positioned in a peripheral vein and extending translurninally through the heart into the pulmonary artery.
References Cited (Backward Citations)
US2531730A
Cited
US3674014A
Cited
US3692018A
Cited
US3788328A
Cited
US3903895A
Cited
US3915171A
Cited
US3983879A
Cited
US3963028A
Cited
US4029104A
Cited
US4204328A
Cited
US4327709A
Cited
US4323071A
Cited
US4323071B1
Cited
US4290428A
Cited
US4301803A
Cited
US4285341A
Cited
US4287892A
Cited
US4411055A
Cited
WO1981003613A1
Cited
US4328056A
Cited
US4413989A
Cited
US4531936A
Cited
US4439186A
Cited
US4573966A
Cited
US4405313A
Cited
US4417576A
Cited
US4535757A
Cited
US4441495A
Cited
US4464175A
Cited
US4496345A
Cited
US4540399A
Cited
US4751924A
Cited
US4714460A
Cited
EP0335205A1
Cited
US4689041A
Cited
US5033998A
Cited
US4648384A
Cited
US4601706A
Cited
US4770652A
Cited
EP0249338A2
Cited
US4753637A
Cited
US4723936A
Cited
US4790825A
Cited
US4771777A
Cited
US4821722A
Cited
US5024668A
Cited
US4804365A
Cited
US5250069A
Cited
US5059167A
Cited
US4796629A
Cited
US4923450A
Cited
US4850969A
Cited
US4848344A
Cited
US4811737A
Cited
US4994032A
Cited
US4917667A
Cited
US5226427A
Cited
US5021045A
Cited
US4889137A
Cited
US4877031A
Cited
US5011469A
Cited
US4877035A
Cited
US4927412A
Cited
US5021044A
Cited
US4943277A
Cited
US5041098A
Cited
US4994033A
Cited
US5171232B1
Cited
US5171232A
Cited
US5112305A
Cited
US5013296A
Cited
US5009636A
Cited
US5049132A
Cited
US5374245A
Cited
US4990143A
Cited
US5106368A
Cited
US5236413A
Cited
US5236413B1
Cited
US5197952A
Cited
US5395330A
Cited
US5527292A
Cited
US5308320A
Cited
US5219326A
Cited
US5380282A
Cited
WO1993007927A1
Cited
US5254089A
Cited
US5324260A
Cited
US5411027A
Cited
US5525388A
Cited
US5487730A
Cited
US5385548A
Cited
US5370640A
Cited
US5423772A
Cited
US5549581A
Cited
US5505698A
Cited
US5488960A
Cited
US5451207A
Cited
WO1995030447A1
Cited
US5597377A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-06-21 | 2002-12-21 | 2003-06-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-06-21 | 2006-12-21 | 2007-06-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-06-21 | 2010-12-21 | 2011-06-22 | $7700.00 | Window Closed / Lapsed |